Invibio Material Solutions, the medical business of UK high-performance polymer producer Victrex, has opened a new product development facility in Leeds in order to...
13.12.2017
- From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas...
04.01.2016
- Pershing Square Capital Management, the hedge fund of billionaire US activist investor Bill Ackman, has trimmed its stake in Canada-headquartered Valeant Pharmaceuticals from...
